JP2013542224A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542224A5 JP2013542224A5 JP2013536813A JP2013536813A JP2013542224A5 JP 2013542224 A5 JP2013542224 A5 JP 2013542224A5 JP 2013536813 A JP2013536813 A JP 2013536813A JP 2013536813 A JP2013536813 A JP 2013536813A JP 2013542224 A5 JP2013542224 A5 JP 2013542224A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition
- den
- den1
- den2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40831010P | 2010-10-29 | 2010-10-29 | |
| US61/408,310 | 2010-10-29 | ||
| PCT/US2011/058026 WO2012154202A1 (en) | 2010-10-29 | 2011-10-27 | Recombinant subunit dengue virus vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542224A JP2013542224A (ja) | 2013-11-21 |
| JP2013542224A5 true JP2013542224A5 (https=) | 2014-12-18 |
| JP6018575B2 JP6018575B2 (ja) | 2016-11-02 |
Family
ID=47139466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013536813A Expired - Fee Related JP6018575B2 (ja) | 2010-10-29 | 2011-10-27 | デングウイルス組換えサブユニットスワクチン |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9198964B2 (https=) |
| EP (1) | EP2632485A4 (https=) |
| JP (1) | JP6018575B2 (https=) |
| KR (1) | KR20130138789A (https=) |
| AU (1) | AU2011367817B2 (https=) |
| BR (1) | BR112013009649A2 (https=) |
| MX (1) | MX344596B (https=) |
| MY (1) | MY166534A (https=) |
| SG (3) | SG10201508700XA (https=) |
| WO (1) | WO2012154202A1 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011119628A2 (en) | 2010-03-23 | 2011-09-29 | The Regents Of The University Of California | Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2625189B1 (en) | 2010-10-01 | 2018-06-27 | ModernaTX, Inc. | Engineered nucleic acids and methods of use thereof |
| AU2011367817B2 (en) | 2010-10-29 | 2015-05-28 | Merck Sharp & Dohme Corp. | Recombinant subunit dengue virus vaccine |
| AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| DE19216461T1 (de) | 2011-10-03 | 2021-10-07 | Modernatx, Inc. | Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon |
| CA3018046A1 (en) | 2011-12-16 | 2013-06-20 | Moderna Therapeutics, Inc. | Modified nucleoside, nucleotide, and nucleic acid compositions |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US8895028B2 (en) * | 2012-07-20 | 2014-11-25 | Arbovax, Inc. | Methods and compositions for dengue virus 3 (DV3) infectious clone |
| PL2922554T3 (pl) | 2012-11-26 | 2022-06-20 | Modernatx, Inc. | Na zmodyfikowany na końcach |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| JP2016523251A (ja) * | 2013-06-21 | 2016-08-08 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | デングウイルスワクチン組成物およびその使用方法 |
| WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
| EP3052521A1 (en) | 2013-10-03 | 2016-08-10 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
| GB201413086D0 (en) | 2014-07-23 | 2014-09-03 | Imp Innovations Ltd And Inst Pasteur | Methods |
| ES2981476T3 (es) * | 2014-12-22 | 2024-10-09 | Merck Sharp & Dohme Llc | Composiciones de vacunas contra el virus del dengue y métodos de uso de las mismas |
| US11241491B2 (en) | 2017-05-23 | 2022-02-08 | The University Of North Carolina At Chapel Hill | Methods and compositions for dengue virus serotype 4 epitopes |
| WO2019112921A1 (en) | 2017-12-07 | 2019-06-13 | Merck Sharp & Dohme Corp. | Formulations of dengue virus vaccine compositions |
| CA3086456A1 (en) | 2017-12-21 | 2019-06-27 | Kirin Holdings Kabushiki Kaisha | Cross-immunizing antigen vaccine and method for preparation thereof |
| WO2019162423A1 (en) * | 2018-02-22 | 2019-08-29 | Sanofi-Aventis Deutschland Gmbh | Variants of porcine trypsin |
| AU2019322828A1 (en) * | 2018-08-14 | 2021-02-25 | Merck Sharp & Dohme Llc | A virus neutralization assay utilizing imaging cytometry |
| KR102301130B1 (ko) * | 2018-12-27 | 2021-09-15 | 주식회사 이뮨메드 | 뎅기출혈열 진단 키트 |
| EP4284426A1 (en) * | 2021-01-28 | 2023-12-06 | Vaccinvent GmbH | Method and means for modulating b-cell mediated immune responses |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136561A (en) | 1995-05-24 | 2000-10-24 | Hawaii Biotechnology Group, Inc. | Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems |
| DE69624815T2 (de) * | 1995-05-24 | 2003-07-10 | Hawaii Biotech Group | Untereinheitsimpfstoff gegen flavivirus infektion |
| WO1999006068A2 (en) * | 1997-07-31 | 1999-02-11 | Hawaii Biotechnology Group, Inc. | Recombinant dimeric envelope vaccine against flaviviral infection |
| US6416763B1 (en) | 1998-08-28 | 2002-07-09 | Hawaii Biotechnology Group, Inc. | Recombinant nonstructural protein subunit vaccine against flaviviral infection |
| US6432411B1 (en) * | 1999-07-13 | 2002-08-13 | Hawaii Biotechnology Group | Recombinant envelope vaccine against flavivirus infection |
| CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| WO2004052293A2 (en) * | 2002-12-11 | 2004-06-24 | Hawaii Biotech, Inc. | Recombinant vaccine against flavivirus infection |
| FR2903605A1 (fr) | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| US20110262472A1 (en) | 2008-04-22 | 2011-10-27 | Cytos Biotechnology Ag | Vaccine compositions for the treatment of dengue fever and uses thereof |
| AU2011367817B2 (en) | 2010-10-29 | 2015-05-28 | Merck Sharp & Dohme Corp. | Recombinant subunit dengue virus vaccine |
-
2011
- 2011-10-27 AU AU2011367817A patent/AU2011367817B2/en not_active Ceased
- 2011-10-27 US US13/881,423 patent/US9198964B2/en active Active
- 2011-10-27 SG SG10201508700XA patent/SG10201508700XA/en unknown
- 2011-10-27 MX MX2013004741A patent/MX344596B/es active IP Right Grant
- 2011-10-27 MY MYPI2013001004A patent/MY166534A/en unknown
- 2011-10-27 EP EP11865332.8A patent/EP2632485A4/en not_active Withdrawn
- 2011-10-27 JP JP2013536813A patent/JP6018575B2/ja not_active Expired - Fee Related
- 2011-10-27 SG SG2013021167A patent/SG189048A1/en unknown
- 2011-10-27 SG SG10201801947YA patent/SG10201801947YA/en unknown
- 2011-10-27 BR BR112013009649A patent/BR112013009649A2/pt not_active Application Discontinuation
- 2011-10-27 WO PCT/US2011/058026 patent/WO2012154202A1/en not_active Ceased
- 2011-10-27 KR KR1020137010730A patent/KR20130138789A/ko not_active Withdrawn
-
2015
- 2015-09-22 US US14/861,425 patent/US10137187B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542224A5 (https=) | ||
| US12208135B2 (en) | Formulations of dengue virus vaccine compositions | |
| WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
| JP2012506411A5 (https=) | ||
| JP5091385B2 (ja) | 弱毒生ワクチン | |
| JP2015535302A (ja) | ビリオン分解に影響を及ぼすフラビウイルスのエンベロープタンパク質変異 | |
| MY166534A (en) | Recombinant subunit dengue virus vaccine | |
| JP2009504654A5 (https=) | ||
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| US9861692B2 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| EP3474891B1 (en) | Vaccine compositions comprising an attenuated mutant zika virus | |
| JP6761015B2 (ja) | 弱毒生アルファウイルス製剤のための組成物および方法 | |
| JP2016504315A5 (https=) | ||
| EP3236997B1 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| JP2018502080A5 (https=) | ||
| JP7046848B2 (ja) | 弱毒化突然変異体ジカウイルスをコードするゲノム配列 | |
| RU2017126043A (ru) | Композиция от бешенства, содержащая адъювант pika | |
| EP4282429A1 (en) | Multivalent covid-19 vaccines based on adenoviral vectors | |
| EA041699B1 (ru) | Составы вакцинных композиций от вируса денге | |
| TH91621B (th) | วิธีการของการก่อภูมิคุ้มกันโรคเพื่อต่อต้าน 4 ซีโรไทป์ของไข้เลือดออก | |
| CN102526710A (zh) | 一种治疗猪病毒病蛋白质组合物 | |
| TH142635A (th) | วัคซีนไวรัสไข้เลือดออกหน่วยย่อยรีคอมบิแนนท์ |